Nama Insights

iShares Genomics Immunology and Healthcare ETF (IDNA)

Health · iShares · NYSE

HealthETF
iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund in the Health category. It has $256.70M in assets, an expense ratio of 0.47% and a 0.72% dividend yield. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioen…
Assets under management$256.70M
Expense ratio0.47%
CategoryHealth
Dividend yield0.72%
NAV$39.93
Fund familyiShares
ExchangeNYSE

Top holdings

The largest positions iShares Genomics Immunology and Healthcare ETF reports, by weight.

HoldingNameWeight
MRNA Moderna Inc 8.85%
TWST Twist Bioscience Corp 6.01%
RVMD Revolution Medicines Inc Ordinary Shares 4.12%
BAYN.DE Bayer AG 4.08%
GMAB.CO Genmab AS 4.00%
REGN Regeneron Pharmaceuticals Inc 3.76%
MRK Merck & Co Inc 3.66%
VRTX Vertex Pharmaceuticals Inc 3.65%
INCY Incyte Corp 3.60%
4502.T Takeda Pharmaceutical Co Ltd 3.51%

Other Health ETFs

Explore live IDNA data on Nama Insights →